For maintenance and general antioxidant support, oral is reasonable
Research References Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
Retatrutide's known side effect profile from trials includes nausea, vomiting, diarrhoea, decreased appetite, and injection-site reactions effects consistent with other GLP-1-based therapies
A 2026 consumer guide covering the best BPC-157 oral supplements, ingredient transparency, and purchasing considerations provides additional context on what to look for when comparing peptide supplement options
425 mg Decaffeinated Green Tea Leaf Extract ( Camellia sinensis ) (Standardized to 50% EGCG)
Tirzepatide is particularly effective for individuals who want a clinically supported solution to achieve significant, lasting weight reduction while supporting their overall metabolic wellness